Bill C-9 is Canada’s legislation to implement the WTO General Council Decision of 30 August 2003. The bill, therefore, should fully reflect the flexibility that the WTO Decision creates for countries to use compulsory licensing to import cheaper, generic phramaceutical products.
“We are following up to our letter of 14 January, in which, on behalf of our members, we strongly urged the Commission to launch an investigation into the matter of HIV testing of priesthood candidates…”
“On behalf of the Canadian HIV/AIDS Legal Network, COCQ-sida (the Quebec Coalition of Community-Based AIDS Organizations), and our 300 members, we strongly urge the Ministry of Health and Social Services to fund, as a matter of urgency, a province-wide campaign against HIV/AIDS-related stigma and discrimination…”
“In an article in The Gazette of today, it is reported that Commission spokesperson Ginette L’Heureux has said that the Commission “will probably examine this week whether it should launch an investigation at its own initiative” into the matter of HIV testing of priesthood candidates…”
NETWORK NEWS FLASHES Advocates Build Joint Agenda for HIV Microbicides, Treatments and Vaccines Amendment to Canada’s Patent Act: More Work Needed Network Participates in Drafting of Warsaw Declaration A Plan of Action for Canada to Reduce HIV/AIDS-related Stigma and Discrimination Mobilizing Communities to Take Action on Stigma and Discrimination Thai Network of Drug Users Extends … Read more
FEATURES TRIPS from Doha to Cancún … to Ottawa: global developments in access to treatment and Canada’s Bill C-56 Warsaw Declaration on HIV/AIDS and injection drug use adopted CANADIAN NEWS North America’s first supervised injection site opens in Vancouver Ontario: People can now apply for forced HIV testing in certain situations Many people in marginalized … Read more
On 14 November 2003, the Warsaw Declaration: A Framework for Effective Action on HIV/ADS and Injection Drug Use, was adopted at the 2nd International Policy Dialogue on HIV/AIDS. Its purpose is to provide a framework for – finally – “mounting an effective response that will slow and eventually stop the HIV/AIDS epidemic among injecting drug … Read more
In November 2003, Canada introduced legislation to amend the Patent Act so that manufacturers could obtain licences to make generic versions of patented pharmaceutical products for export to countries lacking sufficient capacity to produce their own. This article provides an overview of recent global developments leading up to Canada’s initiative, as well as an analysis … Read more